Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart Failure

Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart Failure

Sacubitril/Valsartan, used for the treatment of heart failure (HF), is a combination of two drugs, an angiotensin receptor inhibitor, and a neprilysin inhibitor, which activates vasoactive peptides. Even though its beneficial effects on cardiac functions have been demonstrated, the mechanisms underp...

Full description

Bibliographic Details
Main Authors: Maura Brioschi, Yuri D’Alessandra, Massimo Mapelli, Irene Mattavelli, Elisabetta Salvioni, Sonia Eligini, Alice Mallia, Veronica Ricci, Erica Gianazza, Stefania Ghilardi, Piergiuseppe Agostoni, Cristina Banfi
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Biomedicines
Subjects:
Sacubitril/Valsartan
heart failure
miRNA
Online Access:https://www.mdpi.com/2227-9059/11/4/1037

Internet

https://www.mdpi.com/2227-9059/11/4/1037

Similar Items